Comparison of Topical Minoxidil 5% in Ethanol Plus Propylene Glycol Versus Minoxidil 5% in Ethanol Alone in Treatment of Women With Female Pattern Hair Loss
NCT ID: NCT04090801
Last Updated: 2019-09-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
60 participants
INTERVENTIONAL
2015-05-30
2017-01-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia
NCT00958750
Clinical Trial in Females With Female Pattern Hair Loss
NCT01145625
Clinical Trial in Females for Female Pattern Hair Loss
NCT01226459
Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia
NCT07080931
Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia
NCT07273799
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The treatment will be continued for six months with regular visits at 3 months intervals.
The medications will be provided in bottles which were identical in shape and color, and were coded by a third party.
Both patients and investigator will be blinded to the medication. Disclosure of the codes will be done, by a third party, at the end of the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Topical minoxidil 5% in 90% ethanol and 5% propylene glycol
Group A applied topical minoxidil 5% in 90% ethanol and 5% propylene glycol
Topical minoxidil 5% in 90% ethanol and 5% propylene glycol
Topical minoxidil 5% in pure ethanol alone
Group B applied topical minoxidil 5% in pure ethanol alone
Topical minoxidil 5% in pure ethanol alone
The treatment will be continued twice daily.for six months with regular visits at 3 months intervals.
Placebo
Group C applied pure ethanol (placebo)
Placebo (Ethanol)
The treatment will be continued twice daily.for six months with regular visits at 3 months intervals.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Topical minoxidil 5% in 90% ethanol and 5% propylene glycol
Topical minoxidil 5% in pure ethanol alone
The treatment will be continued twice daily.for six months with regular visits at 3 months intervals.
Placebo (Ethanol)
The treatment will be continued twice daily.for six months with regular visits at 3 months intervals.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
60 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohammed Abu El-Hamd
Assistant Professor of Dermatology, Venereology and Andrology Department, Faculty of Medicine, Sohag University, Egypt.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohammed Abu El-Hamd, MD
Role: PRINCIPAL_INVESTIGATOR
Faculty of Medicine, Sohag University, Egypt.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5/2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.